Search results
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 2 hours agoAn FDA committee assessing the safety and effectiveness of Eli Lilly and Company’s LLY Alzheimer's...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab | CNN
CNN.com· 13 hours agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse ...
FDA advisory panel recommends new Alzheimer's drug after scrutiny
UPI· 2 hours agoEli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's:...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 20 hours agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 6 hours agoJohnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
Waddell & Associates LLC Lowers Holdings in Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 1 day agoWaddell & Associates LLC trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 14.0% in the 4th quarter, according to its most recent ...
Google parent Alphabet poaches new CFO Anat Ashkenazi from Eli Lilly
NY Post via Yahoo Finance· 6 days agoAnat Ashkenazi wil take over on July 31. Google parent Alphabet has poached Anat Ashkenazi from...
Trending: Eli Lilly's Alzheimer's Treatment Gets FDA Advisory Panel Backing
Morningstar· 2 hours ago09:37 ET -- Eli Lilly is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Advisers ...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 17 hours agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...